XML 47 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Schedule of Segment Information
Three Months
Ended March 31,
Agriculture1
Electronics &
Communications
Industrial Biosciences
Nutrition & Health
Performance
Materials
Protection Solutions
Other
Total
2017
 

 

 
 
 

 

 

 

Net sales
$
3,928

$
510

$
368

$
789

$
1,368

$
747

$
33

$
7,743

Operating earnings
1,236

89

75

121

355

177

(62
)
1,991

 
 
 
 
 
 
 
 
 
2016
 

 

 
 
 

 

 

 

Net sales
$
3,786

$
452

$
352

$
801

$
1,249

$
729

$
36

$
7,405

Operating earnings
1,101

59

63

104

273

176

(59
)
1,717


1. 
As of March 31, 2017, Agriculture net assets were $9,131, an increase of $2,789 from $6,342 at December 31, 2016. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.
Reconciliation to Consolidated Income Statements
 
Three Months Ended March 31,
 
2017
2016
Total segment operating earnings
$
1,991

$
1,717

Significant pre-tax benefits (charges) not included in segment operating earnings
14

(68
)
Non-operating pension and other post employment benefit costs
(104
)
(74
)
Exchange losses
(59
)
(121
)
Corporate (expenses) income1,2,3,4,5
(196
)
273

Interest expense
(84
)
(92
)
Income from continuing operations before income taxes
$
1,562

$
1,635


1. 
Includes transaction costs associated with the planned merger with Dow and related activities of $(170) and $(24) in the three months ended March 31, 2017 and 2016, respectively, which were recorded in selling, general and administrative expenses in the company's interim Consolidated Income Statements. See Note 2 for additional information.
2. 
Includes a $(4) charge recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the three months ended March 31, 2017 associated with the 2017 restructuring program. See Note 4 for additional information.
3. 
Includes a $47 benefit on accrued interest reversals recorded in other income, net, in the company's interim Consolidated Income Statement for the three months ended March 31, 2017, related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations. See Note 6 for additional information.
4. 
Includes a gain of $369 associated with the sale of DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. The gain was recorded in other income, net, in the company's interim Consolidated Income Statement for the three months ended March 31, 2016. See Note 3 for additional information.
5. 
Includes a $14 net benefit recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the three months ended March 31, 2016 associated with the 2016 global cost savings and restructuring plan. See Note 4 for additional information.
Schedule Of Additional Segment Details
Significant Pre-tax Benefits (Charges) Not Included in Segment Operating Earnings
The three months ended March 31, 2017 and 2016, respectively, included the following significant pre-tax benefits (charges) which are excluded from segment operating earnings:
 
Three Months Ended March 31,
 
2017
2016
Agriculture1,4,5
$
—

$
(73
)
Electronics & Communications2,4
(5
)
7

Industrial Biosciences2,4
(6
)
1

Nutrition & Health2,3,4
160

1

Performance Materials2,4
(11
)
(4
)
Protection Solutions2,4
(124
)
3

Other4
—

(3
)
 
$
14

$
(68
)
1. 
Includes $23 for reduction in accrual recorded in other operating charges in the company's interim Consolidated Income Statement for the three months ended March 31, 2016, for customer claims related to the use of the Imprelis® herbicide.
2. 
Includes a $(148) restructuring charge in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the three months ended March 31, 2017, associated with the 2017 restructuring program. See Note 4 for additional information.
3. 
Includes a $162 gain recorded in other income, net, in the company's interim Consolidated Income Statement for the three months ended March 31, 2017, associated with the sale of the company's global food safety diagnostic business. See Note 3 for additional information.
4. 
Includes a $(16) net restructuring charge in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the three months ended March 31, 2016, associated with the 2016 global cost savings and restructuring program. See Note 4 for additional information.
5.  
Includes a $(75) restructuring charge recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the three months ended March 31, 2016, related to the decision not to re-start the insecticide manufacturing facility at the La Porte site located in La Porte, Texas. See Note 4 for additional information.